z-logo
open-access-imgOpen Access
Could Ambroxol reduce cytokines in hepatic ischemia-reperfusion injury in rats?
Author(s) -
Çağrı Gültekin,
Ahmet Özer Şehirli,
Şule Çetınel,
Serkan Sayıner
Publication year - 2022
Publication title -
bratislavské lekárske listy/bratislava medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.387
H-Index - 32
eISSN - 1336-0345
pISSN - 0006-9248
DOI - 10.4149/bll_2022_060
Subject(s) - ambroxol , ischemia , medicine , reperfusion injury , proinflammatory cytokine , pharmacology , hepatocyte , anesthesia , tumor necrosis factor alpha , inflammation , chemistry , biochemistry , in vitro
The aim of the study is to examine the effect of Ambroxol on TNF-α and IL-1β released after liver ischemia-reperfusion injury.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom